Gambling With Cardiovascular Disease Risk Models: How to Choose and How to Use
| Autor: | Hiba Jekki, Ilka Lowensteyn, Steven A. Grover, Mohammed Kaouache |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
medicine.medical_specialty
MEDLINE Disease 030204 cardiovascular system & hematology 03 medical and health sciences 0302 clinical medicine Diabetes mellitus Humans Medicine 030212 general & internal medicine Risk factor Intensive care medicine Dyslipidemias Models Statistical business.industry medicine.disease 3. Good health Cardiovascular Diseases Heart Disease Risk Factors Hypertension Disease risk Cardiology and Cardiovascular Medicine business Lifestyle habits Risk assessment Dyslipidemia |
| Zdroj: | Canadian Journal of Cardiology. 37:786-789 |
| ISSN: | 0828-282X |
| DOI: | 10.1016/j.cjca.2021.02.013 |
| Popis: | Cardiovascular risk assessment has been shown to improve physicians' and patients' understanding of an individual's future risk of cardiovascular disease (CVD). It has also been shown to improve the management of cardiovascular risk factors including hypertension and dyslipidemia. Given the challenges of engaging patients to adhere to healthy lifestyle habits or take medications for hypertension and dyslipidemia, the primary role of CVD risk assessment should be to open a discussion about the patient's risk for CVD and associated conditions like adult-onset diabetes. Calculating a patient's long-term risk and estimating the benefits of lifestyle changes or risk factor management may then be used to support long-term patient adherence. However, risk assessment is only a first step and must be followed by evidence-based health-promotion strategies and risk factor medications that have been proven to work. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect